The rationale for the use of measles post-exposure prophylaxis in pregnant women: A review

Journal of Obstetrics and Gynaecology

Volumn 29, Issue 7, 2009, Pages 572-575

  Manikkavasagan, G ^a   Ramsay, M ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Immunoglobulin; Measles; Post exposure prophylaxis; Pregnancy

Indexed keywords

FEMALE; FETUS DISEASE; FETUS OUTCOME; FETUS WASTAGE; HIGH RISK PREGNANCY; HUMAN; INFECTION PREVENTION; INFECTION RISK; INFECTION SENSITIVITY; MATERNAL MORBIDITY; MEASLES; NEWBORN INFECTION; PERINATAL INFECTION; PREGNANCY; PREGNANCY COMPLICATION; PREGNANT WOMAN; PREMATURITY; PRIORITY JOURNAL; REVIEW; SUBACUTE SCLEROSING PANENCEPHALITIS;

FEMALE; HUMANS; MEASLES; POST-EXPOSURE PROPHYLAXIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 70350664681     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.1080/01443610903104478     Document Type: Review

References (29)

1. Advisory Committee on Epidemiology. 1995. Guidelines for the control of measles outbreaks in Canada. Canada Communicable Disease Report 21-21 Available at: http://www.phacaspc.gc.ca/ publicat/ccdrrmtc/95vol21/dr2121ea.html (Accessed 28 May 2008).
2. Advisory Committee on Immunization Practices (ACIP). 1998. Measles, mumps and rubella - vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps. Morbidity and Mortality Weekly Report 47(RR-8) 1-57.
3. Atmar RL, Englund JA, Hammill H. 1992. Complications of measles during pregnancy. Clinical Infectious Diseases 14:217-226.
4. Black FL, Yannet H. 1960. Inapparent measles after gamma globulin administration. Journal of American Medical Association 173:1183-1188.
5. Campbell H, Andrews N, Brown KE, Miller E. 2007. Review of the effect of measles vaccination on the epidemiology of SSPE. International Journal of Epidemiology 36:1334-1348.
6. Chiba ME, Saito M, Suzuki N, Honda Y, Yaegashi N. 2003. Measles infection in pregnancy. Journal of Infection 47:40-44.
7. Cruzado D, Massery-Spicher, Roux L, Delavelle J, Picard F, Haenggeli CA. 2002. Early onset and rapidly progressive SSPE. European Journal of Paediatrics 161:438-441.
8. Dasopoulou M, Covanis A. 2004. Subacute sclerosing panencephalitis after intrauterine infection. Acta Paediatrica 93:1251-1253.
9. Eberhart-Phillips JE, Frederick PD, Baron RC, Mascola L. 1993. Measles in pregnancy: a descriptive study of 58 cases. Obstetrics and Gynecology 82:797-801.
10. Ali ME, Albar HM. 1997. Measles in pregnancy: maternal morbidity and perinatal outcome. International Journal of Gynaecology and Obstetrics 59:109-113.
11. Endo A, Izumi H, Miyashita M, Taniguchi K, Okubo O, Harada K. 2001. Current efficacy of post exposure prophylaxis against measles with immunoglobulin. Journal of Paediatrics 138:926-928.
12. Gazala E, Karplus M, Liberman JR, Sarov I. 1985. The effect of maternal measles on the foetus. Paediatric Infectious Disease Journal 4:203-204.
13. Gershon AA. 1990. Chicken pox, measles and mumps. In: Remington JS, Klein JO, editors, Infectious diseases of the fetus and newborn infant. Philadelphia: WB Saunders. pp 395-445.
14. Jespersen CS, Lttauer J, Sagild U. 1977. Measles as a cause of foetal defects. A retrospective study of ten measles epidemics in Greenland. Acta Paediatrica Scandinavica 66:367-372.
15. Kobayashi K, TajimaM, Toishi S, Fujimori K, Suzuki Y Udagawa H. 2005. Fetal growth restriction associated with measles virus infection during pregnancy. Journal of Perinatal Medicine 33:67-68.
16. Moroi K, Sito S, Kurata T, Sata T, Yanagida M. 1991. Fetal death associated with measles virus infection of the placenta. American Journal of Obstetrics and Gynecology 164:1107-1108.
17. National Disease Surveillance Centre. 2002. Guidelines for the control of measles in Ireland. Recommendations of Measles Sub-committee of Scientific Advisory Committee. Available at: http://www.ndsc.ie/hpsc/AZ/VaccinePreventable/ Measles/Public ations/File,938,en.pdf (Accessed 28 May 2008).
18. Office of National Statistics. 2006. Available at: http://www.stati stics.gov.uk/cci/nugget.asp?ID=951 (Accessed 28 May 2008).
19. Ohyama M, Fukui T, Tanaka Y, Kato K, Hoshino R, Sugawara T, et al. 2001. Measles virus infection in the placenta of monozygotic twins. Modern Pathology 14:1300-1303.
20. Ordman CW, Jennings JR, Janeway CA. 1945. Chemical, clinical and immunological studies on the products of human plasma fractionation. XII. The use of concentrated normal human serum gamma globulin (human immune serum globulin) in the prevention and attenuation of measles. Journal of Clinical Investigation 23:541-549.
21. Ramsay M, Gay N, Miller E, Rush M, White J, Morgan-Capner P, et al. 1994. The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign. Communicable Disease Report 4:141-145.
22. Salisbury D, Ramsay M, Noakes K. 2006. In: Salisbury D, Ramsay M, Noakes K, editors, Immunisation against infectious disease. 4th ed. London: The Stationery Office. pp 209-234.
23. Stein SJ, Greenspoon JS. 1991. Rubeola during pregnancy. Obstetrics and Gynecology 78:925-929.
24. Sawaishi Y, Abe T, Yano T, Ishikawa K, Takada G. 1999. SSPE following neonatal measles infection. Paediatric Neurology 20:63-65.
25. Siegel M. 1973. Congenital malformations following chickenpox, measles, mumps and hepatitis. Results of a Cohort study. Journal of American Medical Association 226:1521-1524.
26. Stokes J, Maris EP, Gellis SS. 1944. Chemical, clinical, and immunological studies on the products of human fractionation. XI. The use of concentrated normal human serum gamma globulin (human immune serum globulin) in the prophylaxis and treatment of measles. Journal of Clinical Investigation 23:531-540.
27. Strebel PM, Papania MJ. 2008. Measles vaccine. In: Plotkin S, Orenstein W, Offit P, editors, Vaccines. 5th ed. Philadelphia: WB Saunders. pp 353-398.
28. Vyse AJ, Gay NJ, Hesketh LM, Pebody R, Morgan-Capner P, Miller E. 2006. Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiology and Infection 134:1303-1312.
29. Zwiauer K, Forstenpontner E, Popow-Kraupp T, Hauser E, Jellinger KA. 1995. Rapid progressive subacute sclerosing panencephalitis after perinatally acquired measles infection. Lancet 345:1124.